Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Multicenter Study to Evaluate the Safety and Efficacy of PEP005 Topical Gel When Used to Treat Actinic Keratoses on the Head (Face or Scalp)

ClinicalTrials.gov ID: NCT00700063

Public ClinicalTrials.gov record NCT00700063. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 3, 2026, 2:44 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Double-blind, Vehicle-controlled, Dose-ranging Study to Evaluate the Safety and Efficacy of 0.005%, 0.01% and 0.015% PEP005 Topical Gel When Used to Treat Actinic Keratoses on the Head (Face or Scalp)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This Phase IIb study is designed to assess the safety and efficacy of 0.005%, 0.01% and 0.015% PEP005 Topical Gel when applied to an area of skin, containing 4-8 AK lesions on the face or scalp.

Study identification

NCT ID
NCT00700063
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Peplin
Industry
Enrollment
265 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2008
Primary completion
Sep 30, 2008
Completion
Sep 30, 2008
Last update posted
Apr 13, 2015

2008

United States locations

U.S. sites
25
U.S. states
14
U.S. cities
23
Facility City State ZIP Site status
Burke Pharmaceutical Research Hot Springs Arizona 71913
Dermatology Research of Arkansas Little Rock Arkansas 72205
Koppel Dermatology Los Angeles California 70072
Dermatology Research Associates Los Angeles California 90045
Integrated Research Group Inc Riverside California 92506
Skin Surgery Medical Group Inc San Diego California 92117
470 Castro St Suite 202-204 San Francisco California 94114
Solano Clinical Research Vallejo California 94589
Dermatology Specialists Inc Vista California 92083
Spencer Derm and Skin Surgery Center St. Petersburg Florida 33716
Northwest Clinical Trial Boise Idaho 83704
Altman Dermatology Associates Arlington Heights Illinois 60005
Christie Clinic Champaign Illinois 61820
South Bend Clinic South Bend Indiana 46617
Minnesota Clinical Study Center Fridley Minnesota 55432
TKL Research, Inc. Paramus New Jersey 07652
Academic Dermatology Associates Albuquerque New Mexico 87106
Oregon Medical Research Center Portland Oregon 97223
Philadelphia Institute of Dermatology Philadelphia Pennsylvania 19034
Dermatology Research Associates Nashville Tennessee 37203
DermResearch, Inc. 8140 N. MoPac, Bldg. 3, Suite 120, Austin Texas 78759
Suzanne Bruce and Associates, The Center for Skin Research Houston Texas 77056
Dermatology Clinical Research Center of San Antonio San Antonio Texas 78229
Progressive Clinical Research San Antonio Texas 78229
Dermatology Associates of Tyler Tyler Texas 75703

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00700063, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 13, 2015 · Synced Sep 3, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00700063 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →